<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00145262</url>
  </required_header>
  <id_info>
    <org_study_id>66</org_study_id>
    <nct_id>NCT00145262</nct_id>
  </id_info>
  <brief_title>TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation</brief_title>
  <official_title>Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nagoya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nagoya University</source>
  <brief_summary>
    <textblock>
      Clinical studies have established that implantation of bone marrow mononuclear cells
      (BM-MNCs) or peripheral blood mononuclear cells (PB-MNCs) into ischaemic limbs increases
      collateral vessel formation. We, the investigators at Nagoya University, further investigated
      the efficacy and safety of autologous implantation of BM-MNCs or PB-MNCs in patients with
      severe ischaemic limbs who have no other alternative therapeutic options. We also examined a
      potential limiting factor which reduced the efficacy of therapeutic angiogenesis using cell
      transplantation (TACT).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2003</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <condition>Buerger Disease</condition>
  <condition>Arteriosclerosis Obliterans</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous Bone Marrow Mononuclear Cell Implantation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who have chronic limb ischemia, including rest pain, non-healing ischemic
             ulcers, or both, and who are not candidates for nonsurgical or surgical
             revascularisation.

        Exclusion Criteria:

          -  Poorly controlled diabetes mellitus (hemoglobin A1c [HbA1c] &gt; 6.5% and proliferative
             retinopathy)

          -  Evidence of malignant disorder during the past 5 years

          -  Subjects who cannot survive more than 1 year with other complications

          -  Malignant rheumatic arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toyoaki Murohara, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, Nagoya University Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Murohara Toyoaki</last_name>
    <phone>81-52-744-2149</phone>
    <email>murohara@med.nagoya-u.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiology, Nagoya University Graduate School of Medicine</name>
      <address>
        <city>Nagoya</city>
        <zip>466-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toyoaki Murohara, MD, PhD</last_name>
      <phone>81-52-744-2149</phone>
      <email>murohara@med.nagoya-u.ac.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <reference>
    <citation>Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002 Aug 10;360(9331):427-35.</citation>
    <PMID>12241713</PMID>
  </reference>
  <verification_date>August 2003</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2005</study_first_submitted>
  <study_first_submitted_qc>September 2, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2005</study_first_posted>
  <last_update_submitted>December 29, 2005</last_update_submitted>
  <last_update_submitted_qc>December 29, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2005</last_update_posted>
  <keyword>critical limb ischemia</keyword>
  <keyword>bone marrow mononuclear cells</keyword>
  <keyword>angiogenesis</keyword>
  <keyword>vasculogenesis</keyword>
  <keyword>Arteriosclerosis Obliterans (ASO)</keyword>
  <keyword>Ischemic ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Thromboangiitis Obliterans</mesh_term>
    <mesh_term>Arteriosclerosis Obliterans</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

